3. Duplicative Therapy

Co-administration of two or more LAI atypical antipsychotics is not justified due to limited additional therapeutic benefit and increased risk of adverse effects 1-13.

Patient profiles containing concomitant prescriptions for two or more LAI atypical antipsychotics will be reviewed.